Trevi Therapeutics Announces Fourth Quarter and Year End 2021 Financial Results and Business Update
Interim Analysis in Phase 2 CANAL Trial Showed Primary Efficacy Endpoint of Cough Reduction in Idiopathic Pulmonary Fibrosis was Highly Statistica...
United States Rosalia Scampoli Katie Mcmanus Exchange Commission Company Phase Prnewswire Trevi Therapeutics Inc
Source: businessinsider.com